Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01572038
Title A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive Advanced Breast Cancer (PERUSE)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

breast adenocarcinoma

Therapies

Pertuzumab + Trastuzumab

Nab-paclitaxel

Docetaxel

Paclitaxel

Age Groups: adult
Covered Countries ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.